Stock CAPS CAPSTONE HOLDING CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Capstone Holding Corp. Share Price

Equities

CAPS

US14068E2081

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 06:40:00 12/12/2023 am IST 		5-day change 1st Jan Change
5.2 USD -.--% Intraday chart for Capstone Holding Corp. -.--% -.--%
01/04 Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Capstone Holding Corp. Announces Change in Board of Directors CI
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 61.56M 5.14B Sales 2023 48.35M 4.04B Capitalization 820K 68.4M
Net income 2022 2M 167M Net income 2023 -3M -250M EV / Sales 2022 0.56 x
Net Debt 2022 28.78M 2.4B Net Debt 2023 20.28M 1.69B EV / Sales 2023 0.44 x
P/E ratio 2022
-583 x
P/E ratio 2023
-0.14 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 100%
More Fundamentals * Assessed data

Chart Capstone Holding Corp.

Dynamic Chart

Latest news about Capstone Holding Corp.

Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Capstone Holding Corp. Announces Change in Board of Directors CI
Capstone Holding Corp. Announces CFO Change CI
Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Capstone Therapeutics Corp. announced that it has received $1.498 million in funding CI
Capstone Therapeutics Corp. acquired an unknown stake Instone Co. CI
Capstone Therapeutics Corp. entered into an agreement to acquire an unknown stake in Instone Co. CI
Capstone Therapeutics Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019 CI
Capstone Therapeutics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019 CI
Capstone Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31, 2018 CI
Capstone Therapeutics Corp. Announces Executive Appointments CI
Capstone Therapeutics Corp. announced that it expects to receive $1.01 million in funding CI
Capstone Therapeutics Corp. Announces Resignation of Eric W. Fangmann from the Board of Directors and Audit Committee CI
Capstone Therapeutics Corp. announced that it has received $1 million in funding from BVF Partners LP CI
Capstone Therapeutics Corp. announced that it expects to receive $1 million in funding from BVF Partners LP CI
More news

Press releases Capstone Holding Corp.

Capstone Therapeutics : Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder, BP Peptides, LLC PU
CAPSTONE THERAPEUTICS ANNOUNCES TRANSACTION WITH TOTALSTONE LLC GL
More press releases

Highs and lows

1 year
4.90
Extreme 4.9
20.00
3 years
4.90
Extreme 4.9
37.50
5 years
4.90
Extreme 4.9
37.50
10 years
4.90
Extreme 4.9
390.00
More quotes

Managers and Directors - Capstone Holding Corp.

Managers TitleAgeSince
Michael Toporek CEO
 Chief Executive Officer 59 14/17/14
Edward Schultz DFI
 Director of Finance/CFO - -
Matthew Lipman BRD
 Director/Board Member 45 14/17/14
Members of the board TitleAgeSince
Jock Holliman BRD
 Director/Board Member 70 01/87/01
Michael Toporek CEO
 Chief Executive Officer 59 14/17/14
Matthew Lipman BRD
 Director/Board Member 45 14/17/14
More insiders

Quotes

Date Price Change Volume

Delayed Quote OTC Markets, December 12, 2023 at 06:40 am IST

More quotes

Company Profile

Capstone Holding Corp. operates, through its wholly owned subsidiary, TotalStone, LLC, which is a construction materials company. TotalStone, LLC distributes masonry stone products for residential and commercial construction in the Midwest and Northeast United States. The Company, through its subsidiary, Capstone Beta, LLC, owns equity interest in Diamond Products, LLC, which is a sexual wellness products holding company. Diamond Products, LLC product portfolio includes adult toys, lingerie, games, lotions and creams that are sold globally in over 80 countries through 5,000 retailers as well as e-commerce Website.
Sector
Biotechnology & Medical Research
More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
CAPSTONE HOLDING CORP. Stock Capstone Holding Corp.
-.--% 820K
MODERNA, INC. Stock Moderna, Inc.
+21.49% 47.9B
LONZA GROUP AG Stock Lonza Group AG
+46.85% 41.42B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.39% 40.7B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.92B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+9.88% 25.55B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.76% 19.27B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.54% 12.15B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.68% 12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-0.51% 11.99B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. CAPS Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW